Literature DB >> 10856132

[Recommendations from MENSURA for selection of antimicrobial agents for susceptibility testing and criteria for the interpretation of antibiograms].

.   

Abstract

This document includes the recommendations from the Spanish antibiogram committee (The MENSURA group, Mesa Española de Normalización de la Sensibilidad y Resistencia a los Antimicrobianos, under the auspices of the Sociedad Española de Quimioterapia and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica) for the selection of antimicrobials for susceptibility testing. Separate tables for each group of organism with proposed susceptibility and resistance breakpoints are updated and comparatively presented with those of other groups, such us NCCLS, CA-SFM and BSAC. The susceptibility breakpoint tends to identify the fully susceptible population, which probably lacks any specific resistance mechanism. The analysis of MIC distributions for different homogeneous populations (same species) is used to define breakpoints for susceptibility. The resistance breakpoint is based on pharmacological and clinical data obtained when the corresponding antibiotic is administered with a conventional schedule. The primary objective of the Spanish MENSURA group is to contribute to the international consensus on the establishment of breakpoints.

Mesh:

Substances:

Year:  2000        PMID: 10856132

Source DB:  PubMed          Journal:  Rev Esp Quimioter        ISSN: 0214-3429            Impact factor:   1.553


  9 in total

1.  Comparison and evaluation of antimicrobial susceptibility testing of enterococci performed in accordance with six national committee standardized disk diffusion procedures.

Authors:  G Cotter; C C Adley
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 2.  Setting and revising antibacterial susceptibility breakpoints.

Authors:  John Turnidge; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

3.  Molecular characterization of beta-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan.

Authors:  Li-Yueh Huang; Po-Liang Lu; Te-Li Chen; Fang-Yee Chang; Chang-Phone Fung; L K Siu
Journal:  Antimicrob Agents Chemother       Date:  2010-04-05       Impact factor: 5.191

4.  Long-term use of selective decontamination of the digestive tract does not increase antibiotic resistance: a 5-year prospective cohort study.

Authors:  María E Ochoa-Ardila; Ana García-Cañas; Karen Gómez-Mediavilla; Ana González-Torralba; Inmaculada Alía; Paloma García-Hierro; Nia Taylor; Hendrick K F van Saene; Miguel A de la Cal
Journal:  Intensive Care Med       Date:  2011-07-19       Impact factor: 17.440

Review 5.  Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.

Authors:  Axel Dalhoff
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

6.  Detection of resistance to beta-lactamase inhibitors in strains with CTX-M beta-lactamases: a multicenter external proficiency study using a well-defined collection of Escherichia coli strains.

Authors:  Aida Ripoll; Juan-Carlos Galán; Cristina Rodríguez; Nuria Tormo; Concepción Gimeno; Fernando Baquero; Luis Martínez-Martínez; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2013-10-23       Impact factor: 5.948

7.  Quality control for beta-lactam susceptibility testing with a well-defined collection of Enterobacteriaceae and Pseudomonas aeruginosa strains in Spain.

Authors:  Rafael Cantón; Elena Loza; María Del Carmen Conejo; Fernando Baquero; Luis Martínez-Martínez
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

8.  Antimicrobial susceptibility and mechanisms of resistance to quinolones and beta-lactams in Acinetobacter genospecies 3.

Authors:  A Ribera; F Fernández-Cuenca; A Beceiro; G Bou; L Martínez-Martínez; A Pascual; J M Cisneros; J Rodríguez-Baño; J Pachón; J Vila
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

9.  Serogroup Y meningococcal disease, Colombia.

Authors:  Clara Inés Agudelo; Olga Marina Sanabria; María Victoria Ovalle
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.